Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine plus bupivacaine for pain control after vitrectomy
RBR-9s9hc29Phase 3Not yet recruiting
- Sponsor
- Hospital São Domingos
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Clonidine + bupivacaine peribulbar block with Placebo + bupivacaine peribulbar block (2 arms). Planned start Nov 2025; status: not yet recruiting.
02
Drugs
clonidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on RBR-9s9hc29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9s9hc29.